COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.
Ann Fam Med. 2022 ;20(4):319To describe demographic and clinical characteristics of chronic obstructive pulmonary disease patients managed in US primary care.
Lees meerCan electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial.
BMJ Open. 2022 Jun;12(6):e059929Medication adherence and inhaler technique in patients with asthma remain suboptimal. A digital, smart spacer may support personalised adherence and...
Lees meerA potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study.
ERJ Open Res. 2022 Apr;8(2)https://bit.ly/3P4nOjQ.
Lees meerVariation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry.
Pragmat Obs Res. 2022 ;13:17Little is known about the variability in chronic obstructive pulmonary disease (COPD) management and how it may be affected by patient...
Lees meerPerceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study.
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2312Biologics are an effective therapy for severe asthma. Home administration of biologics by patients is likely to facilitate their accessibility. Yet...
Lees meerImproved health status of severe COPD patients after being included in an integrated primary care service: A prospective cohort study.
Eur J Gen Pract. 2022 Dec;28(1):66Chronic obstructive pulmonary disease (COPD) is a prevalent lung disease. It is assumed that severe patients will receive better treatment in...
Lees meerShort-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2297Expert national/global asthma management recommendations raise the issue whether a safe threshold of short-acting beta-2 agonist (SABA) use without...
Lees meerIs Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist.
J Allergy Clin Immunol Pract. 2022 Jul;10(7):1813Inhaled medications are central to treating asthma and chronic obstructive pulmonary disease (COPD), yet critical inhaler technique errors are made...
Lees meerAllergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice.
Allergy. 2022 Sep;77(9):2618Most patients presenting with allergies are first seen by primary care health professionals. The perceived knowledge gaps and educational needs were...
Lees meerRelationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD-A Systematic Scoping Review.
Biomedicines. 2022 Feb;10(2)Optimal delivery of medication via dry powder inhalers, the most commonly prescribed inhaler type, is dependent on a patient achieving a minimum...
Lees meerPrioritising primary care respiratory research needs: results from the 2020 International Primary Care Respiratory Group (IPCRG) global e-Delphi exercise.
NPJ Prim Care Respir Med. 2022 Jan;32(1):6Respiratory diseases remain a significant cause of global morbidity and mortality and primary care plays a central role in their prevention,...
Lees meerGlobal Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.
J Allergy Clin Immunol Pract. 2022 May;10(5):1202Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for...
Lees meer